Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Raschi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Neurogastroenterology and Motility|January 30, 2017
Association between the use of proton pump inhibitors and cardiovascular events: A note of cautionE Raschi, M Bianchin, E Poluzzi, et al.
Clinical Immunology (Orlando, Fla.)|July 9, 2004
Endothelial cell activation by antiphospholipid antibodiesP L Meroni, E Raschi, C Testoni, et al.
The British Journal of Dermatology|November 13, 2020
The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practiceE Raschi, M La Placa, E Poluzzi, et al.
Rheumatic Diseases Clinics of North America|September 6, 2001
Antiphospholipid antibodies and the endotheliumP L Meroni, E Raschi, C Testoni, et al.
Acta Diabetologica|October 20, 2011
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance databaseE Raschi, C Piccinni, E Poluzzi, et al.
Autoimmunity Reviews|November 18, 2004
Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodiesP L Meroni, E Raschi, C Testoni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 23, 2003
Endothelium activation in the anti-phospholipid syndromeE Raschi, C Testoni, M O Borghi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 20, 2020
Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reductionE Raschi, F Salvo, M La Placa, et al.
Lupus|September 18, 2014
Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cellsM O Borghi, E Raschi, C Grossi, et al.
Annals of the Rheumatic Diseases|December 14, 2005
Infectious origin of the antiphospholipid syndromeY Shoenfeld, M Blank, R Cervera, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Neurogastroenterology and Motility|January 30, 2017
Association between the use of proton pump inhibitors and cardiovascular events: A note of cautionE Raschi, M Bianchin, E Poluzzi, et al.
Clinical Immunology (Orlando, Fla.)|July 9, 2004
Endothelial cell activation by antiphospholipid antibodiesP L Meroni, E Raschi, C Testoni, et al.
The British Journal of Dermatology|November 13, 2020
The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practiceE Raschi, M La Placa, E Poluzzi, et al.
Rheumatic Diseases Clinics of North America|September 6, 2001
Antiphospholipid antibodies and the endotheliumP L Meroni, E Raschi, C Testoni, et al.
Acta Diabetologica|October 20, 2011
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance databaseE Raschi, C Piccinni, E Poluzzi, et al.
Autoimmunity Reviews|November 18, 2004
Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodiesP L Meroni, E Raschi, C Testoni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 23, 2003
Endothelium activation in the anti-phospholipid syndromeE Raschi, C Testoni, M O Borghi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 20, 2020
Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reductionE Raschi, F Salvo, M La Placa, et al.
Lupus|September 18, 2014
Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cellsM O Borghi, E Raschi, C Grossi, et al.
Annals of the Rheumatic Diseases|December 14, 2005
Infectious origin of the antiphospholipid syndromeY Shoenfeld, M Blank, R Cervera, et al.
Pageof 4